Literature DB >> 15349817

Cytoskeletal mechanisms responsible for invasive migration of neoplastic cells.

Jury M Vasiliev1.   

Abstract

Cytoskeletal reorganizations, especially alterations of contractile tension generated by the actin-myosin cortex, are of central importance in the development of the phenotype of morphologically transformed neoplastic cells with invasive behavior. These reorganizations can be regarded as genetically determined aberrations of the physiological reactions of normal cells which are responsible for their ability to undergo exploratory migrations, including epithelio-mesenchymal transformations, invasion of matrix by epithelial tubules etc. It is suggested that these physiological and neoplastic transformations are based on Rho-dependent alterations in contractility. A decrease or an increase in contractility may result in the development of distinct types of invasive phenotypes. These contractility-dependent phenotype alterations may be modified by alterations in the expression of other genes, especially of those coding for components of adhesive structures.

Mesh:

Substances:

Year:  2004        PMID: 15349817     DOI: 10.1387/ijdb.041806jv

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  15 in total

1.  Rac-dependent doubling of HeLa cell area and impairment of cell migration and cell cycle by compounds from Iris germanica.

Authors:  Michal Halpert; Mohamad Abu-Abied; Dror Avisar; Yoni Moskovitz; Osnat Altshuler; Avner Cohen; Mira Weissberg; Joseph Riov; Hugo E Gottlieb; Avichai Perl; Einat Sadot
Journal:  Protoplasma       Date:  2011-01-05       Impact factor: 3.356

Review 2.  Heading off with the herd: how cancer cells might maneuver supernumerary centrosomes for directional migration.

Authors:  Angela Ogden; Padmashree C G Rida; Ritu Aneja
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

3.  Stable knockdown of TPPP3 by RNA interference in Lewis lung carcinoma cell inhibits tumor growth and metastasis.

Authors:  Wenbai Zhou; Jiada Li; Xuanchun Wang; Renming Hu
Journal:  Mol Cell Biochem       Date:  2010-06-23       Impact factor: 3.396

4.  Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.

Authors:  Suzanne Carreira; Jane Goodall; Laurence Denat; Mercedes Rodriguez; Paolo Nuciforo; Keith S Hoek; Alessandro Testori; Lionel Larue; Colin R Goding
Journal:  Genes Dev       Date:  2006-12-15       Impact factor: 11.361

5.  Cutaneous human papillomavirus type 38 E7 regulates actin cytoskeleton structure for increasing cell proliferation through CK2 and the eukaryotic elongation factor 1A.

Authors:  Jiping Yue; Ruchi Shukla; Rosita Accardi; Isabelle Zanella-Cleon; Maha Siouda; Marie-Pierre Cros; Vladimir Krutovskikh; Ishraq Hussain; Yamei Niu; Shiqiong Hu; Michel Becchi; Pierre Jurdic; Massimo Tommasino; Bakary S Sylla
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

6.  Actin disassembly 'clock' and membrane tension determine cell shape and turning: a mathematical model.

Authors:  A Mogilner; B Rubinstein
Journal:  J Phys Condens Matter       Date:  2010-05-19       Impact factor: 2.333

7.  Overexpression of FMNL2 is closely related to metastasis of colorectal cancer.

Authors:  Xi-Ling Zhu; Li Liang; Yan-Qing Ding
Journal:  Int J Colorectal Dis       Date:  2008-07-30       Impact factor: 2.571

Review 8.  The shape of motile cells.

Authors:  Alex Mogilner; Kinneret Keren
Journal:  Curr Biol       Date:  2009-09-15       Impact factor: 10.834

9.  Transforming growth factor beta controls the directional migration of hepatocyte cohorts by modulating their adhesion to fibronectin.

Authors:  Fabien Binamé; Patrice Lassus; Urszula Hibner
Journal:  Mol Biol Cell       Date:  2007-12-19       Impact factor: 4.138

Review 10.  Actin cytoskeleton dynamics linked to synovial fibroblast activation as a novel pathogenic principle in TNF-driven arthritis.

Authors:  Y Vasilopoulos; V Gkretsi; M Armaka; V Aidinis; G Kollias
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.